BSE filing, BSE: 544000. Summary written from the filing by ALFA Finder's alert engine.
City Crops Agro Ltd: key numbers
- Share price
- ₹64.11
- Market cap
- ₹104.6 Cr
- Revenue (annual)
- ₹19.54 Cr
- Net profit (annual)
- ₹-3.93 Cr
- P/E (TTM)
- -26.6×Sector 36.4×
- Promoter holding
- 54.70%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from City Crops Agro Ltd
All →City Crops Agro Board Meeting Date
City Crops Agro intimates a board meeting on 04 Nov 2026 to consider unaudited half-year results for the period ended 30 September 2026. The notice is filed under Regulation 29(1) and carries no results figures.
City Crops Agro Annual General Meeting
City Crops Agro Limited held its 13th Annual General Meeting on September 30, 2026. The meeting discussed financial statements and director appointments.
City Crops Agro Annual General Meeting
City Crops Agro Limited approved the notice for its 13th Annual General Meeting scheduled for September 30, 2026. The meeting will be held via video conferencing.
City Crops Agro Other Announcement
City Crops Agro Limited confirmed its non-applicability as a Large Corporate under SEBI debt-raising norms. This annual compliance filing reflects its current borrowing profile.
City Crops Agro H2 FY26 Results: Net Profit ₹1.9 Cr, Up 58.3% YoY
City Crops Agro Ltd reported revenue from operations of ₹16.3 Cr (-52.2% YoY) and net profit of ₹1.9 Cr (+58.3% YoY) for H2 FY26.
- Key figure
- Net profit ₹1.9 Cr · +58.3% YoY
City Crops Agro Financial Results
City Crops Agro reported audited FY26 financial results and appointed M/s. Jay Pandya & Associates as secretarial auditors. The board meeting concluded at 5:45 P.M.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.